Why the study?
The authors sought to externally validate the SYNTAX score II and investigate the impact of not abiding by its recommendations in patients with left main disease.
Does performing PCI instead of CABG increase 4-year all-cause mortality in patients with left main coronary artery disease for whom SYNTAX score II recommends CABG?
Does performing PCI instead of CABG increase 4-year all-cause mortality in patients with left main coronary artery disease for whom SYNTAX score II recommends CABG?
Non-compliance with SYNTAX score II recommendations for CABG (i.e., performing PCI instead) in patients with left main disease is associated with significantly higher 4-year all-cause mortality.
Answers are grounded in this paper and cite their sources.
SSII offers acceptable mortality discrimination in real-world CABG; extends trial validation to observational cohorts but leaves treatment recommendations untested prospectively.
OBJECTIVES: The SYNTAX score II (SSII) was developed from the SYNTAX trial to predict the 4-year all-cause mortality after left main or multivessel disease revascularization and to facilitate the decision-making process. The SSII provides the following treatment recommendations: (i) coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) (equipoise risk), (ii) CABG preferred (excessive risk for PCI) or (iii) PCI preferred (excessive risk for CABG). We sought to externally validate SSII and to investigate the impact of not abiding by the SSII recommendations in the randomized EXCEL trial of PCI versus CABG for left main disease. METHODS: The calibration plot of predicted versus observed 4-year mortality was constructed from individual values of SSII in EXCEL. To assess overestimation versus underestimation of predicted mortality risk, an optimal fit regression line with slope and intercept was determined. Prospective treatment recommendations based on SSII were compared with actual treatments and all-cause mortality at 4 years. RESULTS: SSII variables were available from EXCEL trial in 1807/1905 (95%) patients. For the entire cohort, discrimination was possibly helpful (C statistic = 0.670). SSII-predicted all-cause mortality at 4 years overestimated the observed mortality, particularly in the highest-risk percentiles, as confirmed by the fit regression line [intercept 2.37 (1.51-3.24), P = 0.003; slope 0.67 (0.61-0.74), P < 0.001]. When the SSII-recommended treatment was CABG, randomized EXCEL patients treated with PCI had a trend towards higher mortality compared with those treated with CABG (14.1% vs 5.3%, P = 0.07) in the as-treat population. In the intention-to-treat population, patients randomized to PCI had higher mortality compared with those randomized to CABG (15.1% vs 4.1%, P = 0.02), when SSII recommended CABG. CONCLUSIONS: In the EXCEL trial of patients with left main disease, the SSII-predicted 4-year mortality overestimated the 4-year observed mortality with a possibly helpful discrimination. Non-compliance with SSII CABG treatment recommendations (i.e. randomized to PCI) was associated with higher 4-year all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Modolo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: